Malignant Brain Neoplasm — Trials

Malignant Brain Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

636 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 192
Recruiting: 110
Ph III recruiting: 4
Growth YoY: +6.3%
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: 39.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (99)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02334722	1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients	completed	Phase 4	81	University of FloridaOTHER	1	Dec 15, 2021	clinicaltrials
NCT02708056	Sugammadex Given for the Reversal of Rocuronium Induced Neuromuscular Blockade Under Sevoflurane Anesthesia in Infants	completed	Phase 4	26	Baskent UniversityOTHER	0	Mar 15, 2016	clinicaltrials